Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
Proceedings of the National Academy of Sciences of the United States of America
|
July 9, 1996
Highly stable expression of a foreign gene from rabies virus vectors
T Mebatsion, M J Schnell, J H Cox, et al.
Cancer Gene Therapy
|
July 1, 1997
Increase of cytotoxic sensitivity of primary human melanoma cells transfected with the interleukin-7 gene to autologous and allogeneic immunologic effector cells
S Finke, B Trojaneck, P Möller, et al.
BMC Emergency Medicine
|
January 23, 2021
Oxygenation laryngoscope vs. nasal standard and nasal high flow oxygenation in a technical simulation of apnoeic oxygenation
H Herff, W A Wetsch, S Finke, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences
|
December 31, 2015
Multimorbidity Patterns in the United States: Implications for Research and Clinical Practice
Richard A Goodman, Shari M Ling, Peter A Briss, et al.
Gene Therapy
|
April 16, 1998
Increase of proliferation rate and enhancement of antitumor cytotoxicity of expanded human CD3+ CD56+ immunologic effector cells by receptor-mediated transfection with the interleukin-7 gene
S Finke, B Trojaneck, P Lefterova, et al.
Gene Therapy
|
April 1, 1997
Lymphocyte apoptosis: induction by gene transfer techniques
O Ebert, S Finke, A Salahi, et al.
Cancer Immunology, Immunotherapy : CII
|
January 6, 1999
Generation of cytokine-induced killer cells using exogenous interleukin-2, -7 or -12
B Zoll, P Lefterova, M Csipai, et al.
Breast Cancer Research : BCR
|
June 20, 2020
KLF4 defines the efficacy of the epidermal growth factor receptor inhibitor, erlotinib, in triple-negative breast cancer cells by repressing the EGFR gene
Melyssa S Roberts, Lindsey J Anstine, Viviane S Finke, et al.
British Journal of Cancer
|
November 27, 1999
Phase I clinical study applying autologous immunological effector cells transfected with the interleukin-2 gene in patients with metastatic renal cancer, colorectal cancer and lymphoma
I G Schmidt-Wolf, S Finke, B Trojaneck, et al.
The Journal of Experimental Medicine
|
March 1, 2006
Intensified and protective CD4+ T cell immunity in mice with anti-dendritic cell HIV gag fusion antibody vaccine
Christine Trumpfheller, Jennifer S Finke, Carolina B López, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
Proceedings of the National Academy of Sciences of the United States of America
|
July 9, 1996
Highly stable expression of a foreign gene from rabies virus vectors
T Mebatsion, M J Schnell, J H Cox, et al.
Cancer Gene Therapy
|
July 1, 1997
Increase of cytotoxic sensitivity of primary human melanoma cells transfected with the interleukin-7 gene to autologous and allogeneic immunologic effector cells
S Finke, B Trojaneck, P Möller, et al.
BMC Emergency Medicine
|
January 23, 2021
Oxygenation laryngoscope vs. nasal standard and nasal high flow oxygenation in a technical simulation of apnoeic oxygenation
H Herff, W A Wetsch, S Finke, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences
|
December 31, 2015
Multimorbidity Patterns in the United States: Implications for Research and Clinical Practice
Richard A Goodman, Shari M Ling, Peter A Briss, et al.
Gene Therapy
|
April 16, 1998
Increase of proliferation rate and enhancement of antitumor cytotoxicity of expanded human CD3+ CD56+ immunologic effector cells by receptor-mediated transfection with the interleukin-7 gene
S Finke, B Trojaneck, P Lefterova, et al.
Gene Therapy
|
April 1, 1997
Lymphocyte apoptosis: induction by gene transfer techniques
O Ebert, S Finke, A Salahi, et al.
Cancer Immunology, Immunotherapy : CII
|
January 6, 1999
Generation of cytokine-induced killer cells using exogenous interleukin-2, -7 or -12
B Zoll, P Lefterova, M Csipai, et al.
Breast Cancer Research : BCR
|
June 20, 2020
KLF4 defines the efficacy of the epidermal growth factor receptor inhibitor, erlotinib, in triple-negative breast cancer cells by repressing the EGFR gene
Melyssa S Roberts, Lindsey J Anstine, Viviane S Finke, et al.
British Journal of Cancer
|
November 27, 1999
Phase I clinical study applying autologous immunological effector cells transfected with the interleukin-2 gene in patients with metastatic renal cancer, colorectal cancer and lymphoma
I G Schmidt-Wolf, S Finke, B Trojaneck, et al.
The Journal of Experimental Medicine
|
March 1, 2006
Intensified and protective CD4+ T cell immunity in mice with anti-dendritic cell HIV gag fusion antibody vaccine
Christine Trumpfheller, Jennifer S Finke, Carolina B López, et al.
Page
of 2